A Phase Ib/II Clinical Study of LBL-007 in Combination With Toripalimab in Treatment of Advanced Malignant Tumors
Clinical trial NCT05102006 · COMPLETED
Trial details
- NCT number
- NCT05102006
- Sponsor
- Nanjing Leads Biolabs Co.,Ltd
- Status
- COMPLETED
- Phase
- Phase 1, Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2021-11-30
- Primary completion
- 2024-05-22
- Enrollment
- 80
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.